What is Grover's disease (transient acantholytic dermatosis)?

What is Grover's Disease?

Grover's disease, also known as transient acantholytic dermatosis, is a pruritic papulovesicular skin disorder characterized by acantholysis (loss of cell-to-cell adhesion) and dyskeratosis, typically presenting as itchy papules and vesicles on the trunk of middle-aged to older adults.

Clinical Presentation

Grover's disease manifests as:

• Itchy papules and vesicle-papules primarily located on the trunk (chest, back, abdomen) 1
• Rough, scaly, or keratotic lesions that can be intensely pruritic 2
• Lesions typically appear on sun-exposed or chronically irritated skin 3

Demographics and Epidemiology

The traditional understanding has been challenged by recent evidence:

• Historically reported with a male-to-female ratio of approximately 4:1, affecting predominantly older white males 1, 2
• Recent data suggests the disease may affect females more frequently than previously recognized—one 2025 study found 65% female patients (15 of 23) 3
• Mean age of onset is around 59 years (range 11-92 years), though younger individuals may be underdiagnosed 1, 3

Pathophysiology and Histology

The microscopic hallmark is acantholysis with or without dyskeratosis, adopting four distinct histologic patterns 4:

1. Darier disease-like pattern
2. Hailey-Hailey disease-like pattern
3. Pemphigus-like pattern
4. Spongiotic/eczematous pattern

Additional features include 4:

• Porokeratosis-like changes with oblique parakeratotic columns
• Intraepidermal vesiculation with multinucleated keratinocytes
• Dermal infiltrate with lymphocytes, eosinophils, and often neutrophils
• Vascular changes including endothelial swelling

Important diagnostic pitfall: The pseudoherpetic variant can mimic herpesvirus infection with multinucleated keratinocytes and intraepidermal vesicles, but lacks true viral cytopathic effect 5. Immunohistochemistry negative for HSV and VZV antigens distinguishes this from true viral infection.

Disease Course

• Spontaneous resolution occurs in approximately 42% of cases within one week to eight months 1
• Can be transient, persistent, or asymptomatic 4
• May have a fluctuant course with relapses 2

Associated Conditions

Grover's disease has been linked to:

• Hematologic malignancies and bone marrow transplantation 2, 6
• Chronic renal failure and solid organ transplantation 7
• Skin cancer: 52% of patients in one cohort had personal history of skin cancer 3
• HIV infection and immunosuppression 2

Critical distinction: In bone marrow transplant recipients, Grover's disease must be histologically differentiated from stage IV graft-versus-host disease to avoid inappropriate intensive immunosuppression 6.

Diagnostic Approach

• Clinical diagnosis based on characteristic truncal papulovesicular eruption with pruritus
• Skin biopsy is essential for definitive diagnosis, particularly to exclude more serious conditions like GVHD in transplant patients or herpesvirus infection in the pseudoherpetic variant 5, 6
• Dermatoscopy (UVFD and sUVRD) shows polygonal scales with specific patterns that may aid diagnosis 3

Treatment

Based on systematic review evidence 1:

First-line therapy: Topical corticosteroids (70% response rate)

Second-line options:

• Systemic retinoids (86% response rate)
• Systemic corticosteroids (64% response rate)

The high spontaneous remission rate (42%) means watchful waiting is reasonable for mild cases, but treatment is warranted for symptomatic relief in pruritic presentations.